Global Information
회사소개 | 문의 | 비교리스트

인공심장판막 : 의료기기 파이프라인 평가

Prosthetic Heart Valves (Cardiovascular) - Global Market Analysis and Forecast Model (COVID-19 market impact)

리서치사 GlobalData
발행일 2020년 06월 상품 코드 654785
페이지 정보 영문
가격
US $ 7,500 ₩ 8,841,000 Excel (Single User License)
US $ 15,000 ₩ 17,682,000 Excel (Site License)
US $ 22,500 ₩ 26,523,000 Excel (Global License)


인공심장판막 : 의료기기 파이프라인 평가 Prosthetic Heart Valves (Cardiovascular) - Global Market Analysis and Forecast Model (COVID-19 market impact)
발행일 : 2020년 06월 페이지 정보 : 영문

세계 인공심장판막 시장의 주요 파이프라인 제품과 임상시험 진행 상황에 대해 조사했으며, 제품의 기능·특성 비교 분석(임상시험 진행 단계별), 주요 기업·조직의 개요 및 대표적 제품, 최근 시장 동향(실적·자본거래 동향 등) 등의 정보를 정리하여 전해드립니다.

제1장 목차

제2장 서론

  • 인공심장판막의 개요

제3장 임상시험중인 제품

  • 파이프라인 제품 : 임상시험 단계별
  • 파이프라인 제품 : 분야별
  • 파이프라인 제품 : 지역별
  • 파이프라인 제품 : 규제 경로별
  • 파이프라인 제품 : 추정 인증 시기별
  • 파이프라인 제품 : 현재 진행중인 임상시험

제4장 인공심장판막 : 임상시험중인 파이프라인 제품, 기업별

  • 인공심장판막 기업 : 임상시험 단계별 파이프라인 제품
  • 인공심장판막 : 임상시험 단계별 파이프라인 제품

제5장 인공심장판막 시장 : 기업·제품의 개요

  • 4C Medical Technologies Inc
  • Abbott Vascular Inc
  • Admedus Ltd
  • Aegis Surgical Limited
  • Annulon
  • AorTech International Plc
  • AorTx, Inc.
  • Arbor Surgical Technologies, Inc.
  • Boston Children's Hospital
  • Boston Scientific Corp
  • Carena Healthcare Ltd
  • Cephea Valve Technologies, Inc.
  • Children's Hospital Boston
  • Clemson University
  • Colibri Heart Valve, LLC
  • Collagen Solutions Plc
  • Colorado State University
  • CorMatrix Cardiovascular Inc
  • CryoLife Inc
  • Cytograft Tissue Engineering Inc(Inactive)
  • Daidalos Solutions BV
  • Direct Flow Medical Inc(Inactive)
  • DSM Dyneema BV
  • Dura LLC
  • Edwards Lifesciences Corp
  • Emory University
  • Endoluminal Technology Research, LLC
  • Florida International University
  • Georgia Institute of Technology
  • Hancock Jaffe Laboratories Inc
  • HighLife SAS
  • HLT, Inc.
  • Hocor Cardiovascular Technologies, LLC
  • Innovia LLC
  • JC Medical, Inc.
  • JenaValve Technology GmbH
  • Leman Cardiovascular SA
  • LivaNova PLC
  • Mayo Clinic
  • Medi-Line S.A.
  • Medtronic plc
  • Meril Life Sciences Pvt Ltd
  • Micro Interventional Devices, Inc.
  • MicroPort Scientific Corp
  • Mitralix Ltd.
  • MitrAssist Ltd.
  • Mitricares
  • MValve Technologies Ltd.
  • NaviGate Cardiac Structures, Inc.
  • Neovasc Inc Company Overview 207
  • Peca Labs, Inc.
  • PolyNova Cardiovascular LLC(Inactive)
  • Polyvascular Corp
  • Rambam Health Care Campus
  • RegenaGraft
  • ReValve Med Inc
  • Revivicor Inc
  • SAS Cormove
  • Sino Medical Sciences Technology Inc
  • Sree Chitra Tirunal Institute for Medical Sciences & Technology
  • St. Jude Medical LLC
  • Stellenbosch University
  • Strait Access Technologies(Pty) Ltd
  • Symetis SA
  • Thoratec Corp
  • Thubrikar Aortic Valve, Inc.
  • Tissue Regenix Ltd
  • Trinity College Dublin
  • TTK Healthcare Ltd
  • University College London
  • University of Arizona
  • University of California
  • University of California Irvine
  • University of California San Francisco
  • University of Cambridge
  • University of Colorado
  • University of Florida
  • University of Iowa
  • University of Minnesota
  • University of Pennsylvania
  • University of South Florida
  • University of Zurich
  • Valtech Cardio Ltd
  • ValveXchange, Inc.(Inactive)
  • Vascular Concepts Ltd
  • Venus MedTech
  • VueKlar Cardiovascular Ltd(Inactive)
  • Xeltis AG

제6장 인공심장판막 시장 : 최근 동향(총 19건)

제7장 부록

KSA 18.07.03

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

Prosthetic Heart Valves (Cardiovascular) - Global Market Analysis and Forecast Model (COVID-19 market impact)

Prosthetic Heart Valves (Cardiovascular) - Global Market Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within Cardiovascular Devices therapeutic area.

The model discusses in detail the impact of COVID-19 on Prosthetic Heart Valves market for the year 2020 and beyond. Increase in aging population across the globe and the associated valvular degeneration is a major driving factor of the Prosthetic Heart Valve market. Prevalence of valvular heart diseases increases with the age. Globally over 100 million people are affected by Valvular Heart Diseases including cases Valve Stenosis and Regurgitation.

Depending on the severity of the condition Valvular Heart Diseases can be treated by surgical repair or replacement procedures using prosthetic heart valves. Mechanical heart valves are generally made of non-physiological materials with a mobile occluder, which is made of rigid materials. This segment comprises of Mechanical Sutured Mitral Valve Replacements and Mechanical Sutured Aortic Valve Replacements.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Prosthetic Heart Valves and evolving competitive landscape -

  • Insightful review of the key industry trends.
  • Annualized total Prosthetic Heart Valves market revenue by segment and market outlooks from 2015-2030.
  • Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

  • Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
  • SWOT analysis for Prosthetic Heart Valves market.
  • Competitive dynamics insights and trends provided for Prosthetic Heart Valves market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

  • Country specific overview of the healthcare system.
  • Country specific reimbursement policies.
  • Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Edwards Lifesciences Corp , Abbott Laboratories, Medtronic plc , LivaNova PLC , CryoLife Inc , Lepu Medical Technology (Beijing) Co Ltd , TTK Healthcare Ltd , Braile Biomedica Ltda and Others ,

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

  • CMO executives who must have deep understanding of the Prosthetic Heart Valves marketplace to make strategic planning and investment decisions.
  • Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
  • Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

  • Understand the impact of COVID-19 on Prosthetic Heart Valves market.
  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving Prosthetic Heart Valves market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Prosthetic Heart Valves market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Track device sales in the global and country-specific Prosthetic Heart Valves market from 2015-2030.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
Back to Top
전화 문의
F A Q